Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-12-27
2005-12-27
Cook, Rebecca (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S653000, C514S648000
Reexamination Certificate
active
06979689
ABSTRACT:
A composition of an antitussive, a decongestant, and diphenhydramine as an antihistamine to treat upper respiratory and oral pharyngeal congestion and related symptoms in a patient. In addition to providing antihistamine effects, diphenhydramine also provides effects as an anti-cholinergic, an analgesic, an antitussive, and an analgesic adjuvant.
REFERENCES:
patent: 5458879 (1995-10-01), Singh et al.
patent: 5681577 (1997-10-01), Lech et al.
patent: 6160020 (2000-12-01), Ohannesian et al.
patent: 2003/0049318 (2003-03-01), Davis et al.
patent: 2003/0077321 (2003-04-01), Kiel et al.
patent: 2004/0029864 (2004-02-01), MacMillan
patent: 2005/0020509 (2005-01-01), Kiel et al.
patent: WO 85/O4589 (1985-10-01), None
patent: WO 94/8870 (1994-12-01), None
patent: WO 95/O7103 (1995-03-01), None
Complete Drug Reference, 1995, pp. 306-309.
MEDLINE 1998358208, McLeod et al, Pharmacology, Aug. 1998 57 (2) 57-64, abstract.
MEDLINE AN 83227600, Lang et al, Advances in Neurology 1983 37 193-200, abstract.
MEDLINE AN 96216810, Di Pietra et al, J. Chromatography Apr. 5, 1996 729(1-2) 355-61, abstract.
EMBASE AN 78384809, Massoud, J. Pediatrics 1978 Feb. 1993 308, abstract.
CA59:28335, BE 622696 19630115, abstract.
WPIDS AN 1985-146685, Sunshine et al, BE901667 19850529, abstract.
DRUGU AN 2001-22049, Raffa R, J. Clin. Pharm. Ther., 26(2) 81-85, 2001.
DRUGU AN 1989-19247, Wolters et al, Can. Med. Asooc. J., 140(5) 507-13, 1989, abstract.
MEDLINE AN 97217824, Humphries et al, J burn care & rehab., Jan.-Feb. 1997, 18 (1 pt 1) 34-6, abstract.
Endal®HD Syrup, <URL http://www.axisvisual.com/ed/pages/syrup.html> pp 1-2 Oct. 21, 2002.
Endal® HD Plus Syrup, <URL http://www.axisvisual.com/ed.pages/syrup—plus.html> pp 1-3 Oct. 21, 2002.
Endal® Time Release Tablets Nasal Decongestant, <URL http://www.axisvisual.com/ed/page
asal.html> pp 1-2 Oct. 21, 2002.
Endal® Expectorant, <URL http://www.axisvisual.com/ed/pages/expectorant.html> pp 1-2 Oct. 21, 2002.
International Search Report,mailedJun. 2, 2004.
Storms et al. ,SCH 434: A new antihistamine/decongestant for seasonal allergic rhinitis, Journal of Allergy and Clinical Immunology, Mosby , vol. 83, No. 6, Jun. 1989, pp. 1083-1090, XP000990053.
Barris,Use of Benadryl for Symptomatic Relief of “Thalamic Pain”, Neurology, 2 (1952), 59-64.
Bluhm, et al.,Potentiation of Oploid Analgesia by H1and H2Antagonists, Life Sciences, 31 (1982), 1229-1232.
Santiago-Palma et al.,Diphenhydramine as an Analgesic Adjuvant in Refractory Cancer Pain, Journal of Pain and Symptom Management, 22:2 (2001), 699-703.
Rumore et al.,Clinical Efficacy of Antihistamines as Analgesics, Pain, 25 (1986), 7-22.
Rumore, et al.,Analgesic Effects of Antihistaminics, Life Sciences, 36:5 (1985), 403-416.
Gonzales Gilbert R.
Jennings Thomas P.
Schellenger Norman D.
Cook Rebecca
PediaMed Pharmaceuticals, Inc.
Wood Herron & Evans L.L.P.
LandOfFree
Compositions and methods for treating upper respiratory... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating upper respiratory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating upper respiratory... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3510396